SCHEMBL12845229

SCHEMBL12845229

C=C(C)C(=O)NCCc1ccc(N(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.50
ALDH1A1 P00352 2/20 0.50
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
PLAAT5 Q96KN8 11/20 0.49
PLAAT4 Q9UL19 11/20 0.49
PLAAT3 P53816 10/20 0.49
PLAAT2 Q9NWW9 10/20 0.49
KDM4E B2RXH2 3/20 0.47
MEN1 O00255 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C19 P33261 1/20 0.47
KMT2A Q03164 1/20 0.47
HPGD P15428 1/20 0.47
ESRRG P62508 1/20 0.45
F13A1 P00488 1/20 0.44
CA12 O43570 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1027805 0.86 SMN1; SMN2 (0.64) SMN1; SMN2ALDH1A1NPC1RAB9APLAAT5
SCHEMBL13876768 0.80 ALDH1A1 (0.78) SMN1; SMN2ALDH1A1NPC1RAB9APLAAT5
SCHEMBL2078764 0.79 POLB (0.61) SMN1; SMN2ALDH1A1NPC1RAB9ACYP1A2
SCHEMBL105520 0.78 KDM4E (0.71) SMN1; SMN2ALDH1A1NPC1RAB9APLAAT5
SCHEMBL3279011 0.77 MTNR1B (0.71) SMN1; SMN2ALDH1A1NPC1RAB9AKDM4E
SCHEMBL554715 0.77 KMT2A (0.56) SMN1; SMN2ALDH1A1NPC1RAB9AMEN1
SCHEMBL15359146 0.76 ESRRG (0.54) SMN1; SMN2ALDH1A1NPC1RAB9APLAAT5
SCHEMBL13808732 0.76 SMN1; SMN2 (0.57) SMN1; SMN2ALDH1A1NPC1RAB9APLAAT5
SCHEMBL18533665 0.76 SMN1; SMN2 (0.57) SMN1; SMN2ALDH1A1NPC1RAB9APLAAT5
SCHEMBL15492835 0.76 ALDH1A1 (0.56) SMN1; SMN2ALDH1A1NPC1RAB9APLAAT5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110060113-A1 SWITCHABLE SPECIAL EFFECT SUBSTANCES BASF SE (DE) 2011-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110060113-A1 SWITCHABLE SPECIAL EFFECT SUBSTANCES PPARG, PTGER4, NR2E3 SMN1; SMN2 1801/4885ALDH1A1 330/4885NPC1 1399/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.